The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

The supply of GLP-1 drugs like Ozempic has been increasing, but they’re still expensive for most patients. Here are answers ...

We came across a bullish thesis on The Cigna Group (CI) on Antonio Linares’ Substack. In this article, we will summarize the ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Weight-loss drugs are already dropping in price; could they go even lower? - Consumers are now able to pay roughly $500 for ...

The lower out-of-pocket costs come at a time of governmental scrutiny on prescription drug prices ... Cigna Group (NYSE: CI) announced a first-of-its-kind pharmacy benefit offering that make ...

The Cigna Group, together with its subsidiaries ... for financing employer-paid future benefit obligations and stop loss insurance. The company distributes its products and services through ...

While employers aren’t yet reimbursing weight loss drugs en masse, significantly reduced net costs could affect their future ...

Entering text into the input field will update the search result below Home page Seeking Alpha - Power to Investors Search for Symbols, analysts, keywords ...